Page 408 - Avian Virology: Current Research and Future Trends
P. 408
Index | 399
virus isolation 125–26 prevention 373–74
epizootiology 125 REV role in FWPV genome 373
genome structure and organization 120–21 virus replication 371–72
immune responses 125, 377 virus survival strategies 372
infectious agent 120–22 Avian reovirus 179–210
morphology 120 clinical features 191–96
phylogenetic relationships of MPV genomes 121 in commercial poultry other than chicken 195–96
propagation 120 enteric orthoreovirus diseases 192, 193, 194–95
viral nucleic acids and proteins 121 immunosuppression 195
viral protein functions 121–22 other disease problems 195
introduction and history 119–20 respiratory orthoreovirus disease 192, 193–94
pathogenesis 123–24 tenosynovitis/viral arthritis 179, 188, 190, 191–93, 195–96
host range 123–24 continuous cell lines 183–84
transmission and spread 124 cytopathic effects (CPE) 182–83, 184
prevention and control 126–27 diagnosis 200–201
reverse genetics 119, 122–23, 127 immunodiagnostic methods 200
viral replication cycle 122 molecular diagnostic methods 200–201
Avian orthoavulavirus 1 (AOAvV-1) 43, 45, 104 epizootiology 198–200
Avian orthoreovirus (ARV) 179, 180, 187, 188, 189 genetics and reverse genetics 187–88
Avian paramyxoviruses (other than Newcastle disease virus) 85–117. phylogenetic analysis 187–88, 189
See also Newcastle disease virus (NDV); Pigeon paramyxovirus type 1 genome structure and organization 184–86
(PPMV-1) host cell effects 187
amino acid sequence identity and evolutionary divergence estimate of immune responses 198
serotypes 96–97 infectious agent 179–82
antigenic relationships 86–88 classification 179–80
APMV-1 44–45, 64, 66, 68, 85–90, 92–105, 111–13 morphology 180–82
APMV-2 43, 86–87, 89, 90, 92–104, 106–10, 112 phylogenetic tree of Reoviridae 181
APMV-3-21 85–112 propagation 182
classification 85–86 introduction and history 179
disease associated with 89–90 pathogenesis 188–91
gene map of serotypes 93 prevention and control 201–2
general virion structure and replication strategy 90–92 primary cell cultures 182–83, 187–88
geographic distribution 88 viral nucleic acid and proteins 185–86
host range 89, 199 viral replication, stages of 186–87
isolation and identification of 90 in wild avian species 196–98, 202
Murayama virus 106 Avian retrotransposon from chicken genome (ART-CH) 235
NDV compared to serotypes of 86–88 Avian sarcomas 231–32, 234
nucleotide sequence identity and evolutionary divergence estimate of Avibirnavirus 211, 212
serotypes 98–99 Avipoxvirus 365, 370, 371, 374
pathogenesis, role of F protein cleavage site on 112 Avulavirinae 44–45, 85, 92, 107
phylogenetic tree analyses, 100, 105, 106, 111 95
reverse genetics 85, 111–12, 113, 122–23 B
‘rule of six’ 92, 105, 110, 120 Baboon orthoreovirus (BRV) 180, 187
sequence alignments of serotypes 94 Bacterial artificial chromosomes (BACs) 156, 355–56
serotypes, classification, isolation history, genome length, host species, Bacterial synovitis 200
and disease potential of 87–88 Baculovirus expression system 70, 223, 239, 259, 274, 346
serotypes, recently reported 86 Barred Rock chickens 303
vaccine vectors, evaluation as 112 B cell receptors (BCRs) 384, 387
viral proteins 92, 100–104 B cells 356, 383–85, 387
fusion protein 92, 100, 101–2, 104, 112 Betacoronavirus 138, 144, 156
haemagglutinin-neuraminidase protein 100, 102 Betatorqueviruses 250, 251
phosphoprotein gene editing products 103 BF. See Bursa of Fabricius (BF)
Avian pathogenic herpesviruses 297 BF1 385, 386
Avian pneumovirus (APV) 21, 119 BF2 385, 386
Avian pox viruses 365–76 BHV-1 (bovine herpesvirus1) 60
aetiological agent 365–70 Biosecurity measures 22, 69, 71, 199, 200, 201, 335
clinical signs 366–67 Birnaviridae 211, 212, 385
diagnosis 368–70 Black kites 305
inoculation of SPF chickens 369 BLB2 385
transmission 365–66 Blue wing disease 265, 271, 272
virus isolation 369–70 BNK receptor 386
cutaneous form 365–70 Bobwhite quail 196, 283, 305
diphtheritic form 365–70 Bollinger bodies (cytoplasmic inclusion bodies) 365, 366, 368–69, 372
genome 371 Bone marrow
genomic differences among 371 ALV and 236
host-related functions 372 CAV and 249, 255–56, 263, 266, 269– 272
immune responses 370 Borrel bodies 365
immunoblotting 370 Borrelia burgdorferi 60
mixed infections 372–73 Bouba aviaria 365
